title: [Successful therapy of the psychiatric patient with catatonic paranoidal syndrome and monitoring of induced cytokine production].
abstract: The paper reports the case of a 42-year-old woman with a diagnosed catatonic-paranoidal syndrome and a noted dysfunction as regards lymphocyte subpopulation and the production of some cytokins: Tumor Necrosis Factor (TNF) and interferons (IFN). As the first phase of the treatment had proved unsuccessful and there appeared symptoms hinting at the possibility of a subclinical inflammatory process in the brain, parallel to psychiatric therapy, treatment was instituted in the system of successive three-week cycles with Tołpa's Peat Extract (PTT), Selenium and Zinc on a natural yeast basis (Selenium and Zinc preparations) as well as with encortone. After a month of treatment a complete clinical remission was achieved as well as normalization as regards all the tested immunological markers.
authors.affiliation: Z Katedry i Kliniki Psychiatrii AM we Wrocławiu.
authors.forename: J
authors.initials: J
authors.lastname: Leszek
authors.forename: A
authors.initials: A
authors.lastname: Kiejna
authors.forename: J A
authors.initials: JA
authors.lastname: Beszłej
authors.forename: A D
authors.initials: AD
authors.lastname: Inglot
authors.forename: J
authors.initials: J
authors.lastname: Borys
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001402:B-Lymphocytes; D002389:Catatonia / Q000150:complications* / Q000188:drug therapy*; D016207:Cytokines / Q000096:biosynthesis*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D015213:Neuroimmunomodulation; D010259:Paranoid Disorders / Q000150:complications* / Q000188:drug therapy*; D012643:Selenium / Q000627:therapeutic use*; D015032:Zinc / Q000627:therapeutic use*
chemical_list: D014150:Antipsychotic Agents; D016207:Cytokines; D012643:Selenium; D015032:Zinc
vernacular_title: Skuteczne leczenie chorej z zespołem katatoniczno-paranoidalnym i monitorowaniem wytwarzania cytokin.